Net shares · 30d
-4.7K
0 buy · 4.7K sell
Net value · 30d
-$990.4K
$0 in · $990.4K out
Sentiment · 30d
Net selling
0% buying · 100% selling
Open-market trades · 30d
5
0 buy · 4.7K sell
Trading track record · all companies
Not enough open-market trades to chart a track record yet.
Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.
Transactions · 30d
-
NTRA Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$655.3K
3.0K sh · $218.43 avg · 4 lots
Own -2%
-
NTRA Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$335.1K
1.7K sh · $202.84
Own -1%
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| Jun 1, 2026 | NTRA | Sell S | 3.0K4 lots | $655.3K |
| May 26, 2026 | NTRA | Sell S | 1.7K | $335.1K |
Buy Sell Non-market (grant · exercise · gift)
About Moshkevich Solomon
This profile aggregates every SEC Form 4 insider transaction reported by Moshkevich Solomon across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.